Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-05

Clinical Trial Update: Generalized Anxiety Disorder Adjunct Study [Phase 3]

View source ↗

Summary

Phase 3 trial results for an adjunctive therapy in generalized anxiety disorder have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Anxiety, Anxiety Disorders | Phase 3 | Status: COMPLETED | Results posted: 2011-04-05